High Number of Memory T Cells Is Associated with Higher Risk of Acute Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation

Biology of Blood and Marrow Transplantation

Volumn 21, Issue 3, 2015, Pages 569-574

  Loschi, Michael ^a,b   Porcher, Raphael ^c   Peffault de Latour, Regis ^b,d   Vanneaux, Valerie ^b,e   Robin, Marie ^b   Xhaard, Alienor ^b   Sicre de Fontebrune, Flore ^b,d   Larghero, Jerome ^b,d,e   Socie, Gerard ^b,d,e  

^a CENTRE HENRI BECQUEREL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e INSERM   (France)

Author keywords

Acute graft versus host disease; Memory T cell; Na ve T cell; Stem cell transplantation

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CD8+ T LYMPHOCYTE; COHORT ANALYSIS; CORD BLOOD STEM CELL TRANSPLANTATION; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOPHENOTYPING; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; RETROSPECTIVE STUDY; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; ACUTE DISEASE; ADOLESCENT; AGED; ALLOGRAFT; BLOOD; CHILD; FOLLOW UP; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE COUNT; METABOLISM; MIDDLE AGED; PATHOLOGY; PRESCHOOL CHILD; STEM CELL TRANSPLANTATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ALLOGRAFTS; CD8-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; STEM CELL TRANSPLANTATION;

EID: 84922769510     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2014.12.009     Document Type: Article

References (25)

1. Socié G., Blazar B.R. Acute graft-versus-host disease: from the bench to the bedside. Blood 2009, 114:4327-4336.
2. Cutler C., Giri S., Jeyapalan S., et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. JClin Oncol 2001, 19:3685-3691.
3. Mielcarek M., Storer B., Martin P.J., et al. Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow. Blood 2012, 119:2675-2678.
4. Anasetti C., Logan B.R., Lee S.J., et al. Peripheral-blood stem cells versus bone marrow from unrelated donors. NEngl J Med 2012, 367:1487-1496.
5. Reddy P., Socié G., Cutler C., Weisdorf D. GVHD prevention: an ounce is better than a pound. Biol Blood Marrow Transplant 2012, 18:S17-S26.
6. Zhang Y., Joe G., Hexner E., et al. Host-reactive CD8+ memory stem cells in graft-versus-host disease. Nat Med 2005, 11:1299-1305.
7. Chen B.J., Cui X., Sempowski G.D., et al. Transfer of allogeneic CD62L- memory T cells without graft-versus-host disease. Blood 2004, 103:1534-1541.
8. Moncrieffe H., Coles M., Stockinger B. The influence of CD4 T-cell subsetson control of CD4 T-cell-mediated graft-versus-host disease. Immunology 2008, 125:459-468.
9. Berard M., Tough D.F. Qualitative differences between naïve and memory T cells. Immunology 2002, 106:127-138.
10. Sallusto F., Lenig D., Förster R., et al. Two subsets of memory Tlymphocytes with distinct homing potentials and effector functions. Nature 1999, 401:708-712.
11. Croft M., Bradley L.M., Swain S.L. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. JImmunol 1994, 152:2675-2685.
12. Yakoub-Agha I., Saule P., Depil S., et al. Comparative analysis of naïve andmemory CD4+ and CD8+ T-cell subsets in bone marrow and G-CSF-mobilized peripheral blood stem cell allografts: impact of donor characteristics. Exp Hematol 2007, 35:861-871.
13. Chérel M., Choufi B., Trauet J., et al. Naïve subset develops the most important alloreactive response among human CD4(+) T lymphocytes in Human Leukocyte Antigen-identical related setting. Eur J Haematol 2014, 92:491-496.
14. Yakoub-Agha I., Saule P., Depil S., et al. Ahigh proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease inpatients undergoing allogeneic stem cell transplantation for hematological malignancy. Leukemia 2006, 20:1557-1565.
15. Chang Y.-J., Zhao X.-Y., Huo M.-R., Huang X.-J. Expression of CD62L ondonor CD4(+) T cells in allografts: correlation with graft-versus-host disease after unmanipulated allogeneic blood and marrow transplantation. JClin Immunol 2009, 29:696-704.
16. Bleakley M., Heimfeld S., Jones L.A., et al. Engineering human peripheral blood stem cell grafts that are depleted of naïve T cells and retain functional pathogen-specific memory T cells. Biol Blood Marrow Transplant 2014, 20:705-716.
17. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
18. Zhang Y., Louboutin J.-P., Zhu J., et al. Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. JClin Invest 2002, 109:1335-1344.
19. Wang X.-N., Haniffa M.A., Holtick U., et al. Regulatory T-cell suppression of CD8+ T-cell-mediated graft-versus-host reaction requires their presence during priming. [Miscellaneous Article]. Transplant 2009, 88:188-197.
20. Jones S.C., Murphy G.F., Korngold R. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 Tcells to allow an effective graft-versus-leukemia response. Biol Blood Marrow Transplant 2003, 9:243-256.
21. Anderson B.E., McNiff J., Yan J., et al. Memory CD4+ T cells do not induce graft-versus-host disease. JClin Invest 2003, 112:101-108.
22. Bosch M., Dhadda M., Hoegh-Petersen M., et al. Immune reconstitution after anti-thymocyte globulin-conditioned hematopoietic cell transplantation. Cytotherapy 2012, 14:1258-1275.
23. Waller E.K., Logan B.R., Harris W.A.C., et al. Improved survival after transplantation of more donor plasmacytoid dendritic or naïve t cells from unrelated-donor marrow grafts: results from BMTCTN 0201. JClin Oncol 2014, 32:2365-2372.
24. Taylor P.A., Lees C.J., Blazar B.R. The infusion of exvivo activated andexpanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 2002, 99:3493-3499.
25. Beres A.J., Drobyski W.R. The role of regulatory T cells in the biology of graft versus host disease. Front Immunol 2013, 4:163.